Fiona Gaughran
Auto-generated profile, based on publicly available information

Fiona Gaughran

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience King's College London London UK

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2017 in World Psychiatry
Verified
Journal Article
Closed access
PDF file
CCChristoph U. Correll
Christoph U. Correll
MSMarco Solm
Marco Solm
NVNicola Veronese
Nicola Veronese
BBBeatrice Bortolato
Beatrice Bortolato
SRStella Rosson
Stella Rosson
BSBrendon Stubbs
Brendon Stubbs

1 August 2019 in The Lancet Psychiatry
Verified
Journal Article
Open access
JFJoseph Firth
Joseph Firth
NSNajma Siddiqi
Najma Siddiqi
AKAi Koyanagi
Ai Koyanagi
DSDan Siskind
Dan Siskind
SRSimon Rosenbaum
Simon Rosenbaum
BSBrendon Stubbs
Brendon Stubbs

1 March 2017 in American Journal of Psychiatry
Verified
Journal Article
Closed access
OHOliver D. Howes
Oliver D. Howes
RMRob McCutcheon
Rob McCutcheon
OAOfer Agid
Ofer Agid
ABAndrea de Bartolomeis
Andrea de Bartolomeis
NBNico J.M. van Beveren
Nico J.M. van Beveren
CCChristoph U. Correll
Christoph U. Correll

21 September 2017 in World Psychiatry
Verified
Journal Article
Closed access
PDF file
DVDavy Vancampfort
Davy Vancampfort
JFJoseph Firth
Joseph Firth
FSFELIPE BARRETO SCHUCH
FELIPE BARRETO SCHUCH
SRSimon Rosenbaum
Simon Rosenbaum
JMJames Mugisha
James Mugisha
BSBrendon Stubbs
Brendon Stubbs

5 June 2016 in World Psychiatry
Verified
Journal Article
Closed access
PDF file
DVDavy Vancampfort
Davy Vancampfort
CCChristoph U. Correll
Christoph U. Correll
BGBritta Galling
Britta Galling
MPMichel Probst
Michel Probst
MHMarc De Hert
Marc De Hert
BSBrendon Stubbs
Brendon Stubbs

18 July 2018 in European Psychiatry
Verified
Journal Article
Open access
BSBrendon Stubbs
Brendon Stubbs
DVDavy Vancampfort
Davy Vancampfort
MHMats Hallgren
Mats Hallgren
JFJoseph Firth
Joseph Firth
NVNicola Veronese
Nicola Veronese
KKKai G. Kahl
Kai G. Kahl
Physical activity (PA) may be therapeutic for people with severe mental illness (SMI) who generally have low PA and experience numerous life style-related medical complications. We conducted a meta-review of PA interventions and their impact on health outcomes for people with SMI, including schizophrenia-spectrum disorders, major depressive disorder (MDD) and bipolar disorder. We searched major electronic databases until January 2018 for systematic reviews with/without meta-analysis that investigated PA for any SMI. We rated the quality of studies with the AMSTAR tool, grading the quality of evidence, and identifying gaps, future research needs and clinical practice recommendations. For MDD, consistent evidence indicated that PA can improve depressive symptoms versus control conditions, with effects comparable to those of antidepressants and psychotherapy. PA can also improve cardiorespiratory fitness and quality of life in people with MDD, although the impact on physical health outcomes was limited. There were no differences in adverse events versus control conditions. For MDD, larger effect sizes were seen when PA was delivered at moderate-vigorous intensity and supervised by an exercise specialist. For schizophrenia-spectrum disorders, evidence indicates that aerobic PA can reduce psychiatric symptoms, improves cognition and various subdomains, cardiorespiratory fitness, whilst evidence for the impact on anthropometric measures was inconsistent. There was a paucity of studies investigating PA in bipolar disorder, precluding any definitive recommendations. No cost effectiveness analyses in any SMI condition were identified. We make multiple recommendations to fill existing research gaps and increase the use of PA in routine clinical care aimed at improving psychiatric and medical outcomes.